跳至主要内容
临床试验/NCT00632112
NCT00632112Unknown不适用

A Real Life Evaluation of the Performance of a Large Volume Nebulizer

Arkansas Children's Hospital Research Institute1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Nebulizer solution output

研究概览

简要总结

Continuous albuterol has become the standard of care for patients in status asthmaticus. We have previously performed an in-vitro study comparing 4 different brands of continuous nebulizers. We now want to compare the in-vitro with the in-vivo performance of the brand we use. we hypothesize that there will be no difference between in-vivo and in-vitro results.

详细描述

There will be no intervention to the patients. Nebulizers will be used as per current policies and procedures. They will only be marked on the outside at the water level every 2 hours for the first 6 hours. Once ready to be discarded will be collected for laboratory testing Once in the laboratory, nebulizers will be weight on a precision scale without liquid, then they will be filled with normal saline to the first mark (6th hour) and re-weight. The nebulizers will be filled to next mark and re-weight until 200 mls. of total volume are achieved. Solution output will be calculated as the weight difference between the 2 hour periods.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients admitted to Pediatric Intensive Care Unit due to status asthmaticus, requiring continuous albuterol nebulization.

排除标准

  • Patients requiring invasive or non-invasive ventilation.

结局指标

主要结局

Nebulizer solution output

时间窗: every 2 hours for first 6 hours

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验